Complement C4d immunohistochemistry in the assessment of liver allograft biopsy samples: Applications and pitfalls

Liver Transplantation

Volumn 17, Issue 7, 2011, Pages 747-750

  Bellamy, Christopher O C ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C4D; HLA ANTIGEN;

ACUTE GRAFT REJECTION; AUTOIMMUNE HEPATITIS; BILE DUCT OBSTRUCTION; CHRONIC GRAFT REJECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOHISTOCHEMISTRY; LIVER BIOPSY; LIVER GRAFT; LIVER SINUSOID; LIVER TRANSPLANTATION; LYMPHOCYTOTOXICITY; LYMPHOID TISSUE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW;

COMPLEMENT C4B; FEMALE; HEPATITIS; HUMANS; LIVER; LIVER TRANSPLANTATION; MALE; PEPTIDE FRAGMENTS;

EID: 79959824372     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22323     Document Type: Review

References (30)

1. Aguilera I, Sousa JM, Gavilan F, Gomez L, Ã?lvarez-Márquez A, NÃ?ñez-Roldán A,. Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis. Liver Transpl 2011; 17: 779- 788.
2. Kozlowski T, Rubinas T, Nickeleit V, Woosley J, Schmitz J, Collins D, et al. Liver allograft antibody-mediated rejection with demonstration of sinusoidal C4d staining and circulating donor-specific antibodies. Liver Transpl 2011; 17: 357-368.
3. Musat AI, Agni RM, Wai PY, Pirsch JD, Lorentzen DF, Powell A, et al. The significance of donor-specific HLA antibodies in rejection and ductopenia development in ABO compatible liver transplantation. Am J Transplant 2011; 11: 500-510.
4. Demetris AJ, Nakamura K, Yagihashi A, Iwaki Y, Takaya S, Hartman GG, et al. A clinicopathological study of human liver allograft recipients harboring preformed IgG lymphocytotoxic antibodies. Hepatology 1992; 16: 671-681.
5. Demetris AJ, Jaffe R, Tzakis A, Ramsey G, Todo S, Belle S, et al. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988; 132: 489-502.
6. Bellamy CO, Herriot MM, Harrison DJ, Bathgate AJ,. C4d immunopositivity is uncommon in ABO-compatible liver allografts, but correlates partially with lymphocytotoxic antibody status. Histopathology 2007; 50: 739-749. (Pubitemid 46683930)
7. Troxell ML, Higgins JP, Kambham N,. Evaluation of C4d staining in liver and small intestine allografts. Arch Pathol Lab Med 2006; 130: 1489-1496. (Pubitemid 44520715)
8. Sakashita H, Haga H, Ashihara E, Wen MC, Tsuji H, Miyagawa-Hayashino A, et al. Significance of C4d staining in ABO-identical/compatible liver transplantation. Mod Pathol 2007; 20: 676-684. (Pubitemid 46788874)
9. Hadaya K, Ferrari-Lacraz S, Giostra E, Majno P, Moll S, Rubbia-Brandt L, et al. Humoral and cellular rejection after combined liver-kidney transplantation in low immunologic risk recipients. Transpl Int 2009; 22: 242-246.
10. Wilson CH, Agarwal K, Carter V, Burt AD, Hübscher S, Talbot D, et al. Late humoral rejection in a compliant ABO-compatible liver transplant recipient. Transplantation 2006; 82: 988-989. (Pubitemid 44564051)
11. Schadde E, d'Alessandro AM, Musat AI, Torrealba JR, Knechtle SJ,. Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin. Clin Transpl 2006: 479-482.
12. Hori T, Uemoto S, Takada Y, Oike F, Ogura Y, Ogawa K, et al. Does a positive lymphocyte cross-match contraindicate living-donor liver transplantation? Surgery 2010; 147: 840-844.
13. Sawada T, Shimizu A, Kubota K, Fuchinoue S, Teraoka S,. Lobular damage caused by cellular and humoral immunity in liver allograft rejection. Clin Transplant 2005; 19: 110-114. (Pubitemid 40227861)
14. Colvin RB,. Dimensions of antibody-mediated rejection. Am J Transplant 2010; 10: 1509-1510.
15. Nakamura K, Murase N, Becich MJ, Furuya T, Todo S, Fung JJ, et al. Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model. Am J Pathol 1993; 142: 1383-1391. (Pubitemid 24058125)
16. Mengel M, Bogers J, Bosmans JL, Serõn D, Moreso F, Carrera M, et al. Incidence of C4d stain in protocol biopsies from renal allografts: results from a multicenter trial. Am J Transplant 2005; 5: 1050-1056. (Pubitemid 40571253)
17. Setoguchi K, Ishida H, Shimmura H, Shimizu T, Shirakawa H, Omoto K, et al. Analysis of renal transplant protocol biopsies in ABO-incompatible kidney transplantation. Am J Transplant 2008; 8: 86-94.
18. Haga H, Egawa H, Fujimoto Y, Ueda M, Miyagawa-Hayashino A, Sakurai T, et al. Acute humoral rejection and C4d immunostaining in ABO blood-type incompatible liver transplantation. Liver Transpl 2006; 12: 457-464.
19. Watson R, Kozlowski T, Nickeleit V, Woosley JT, Schmitz JL, Zacks SL, et al. Isolated donor specific alloantibody-mediated rejection after ABO compatible liver transplantation. Am J Transplant 2006; 6: 3022-3029.
20. Lorho R, Turlin B, Aqodad N, Triki N, de Lajarte-Thirouard AS, Camus C, et al. C4d: a marker for hepatic transplant rejection. Transplant Proc 2006; 38: 2333-2334. (Pubitemid 46068533)
21. Martelius T, Halme L, Arola J, Hockerstedt K, Lautenschlager I,. Vascular deposition of complement C4d is increased in liver allografts with chronic rejection. Transpl Immunol 2009; 21: 244-246.
22. Schmeding M, Dankof A, Krenn V, Krukemeyer MG, Koch M, Spinelli A, et al. C4d in acute rejection after liver transplantationâa valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant 2006; 6: 523-530. (Pubitemid 43382138)
23. Ali SA, Shah V, McKinnon R, Van Harn M, Janakiraman N,. Frequent expression of C4d in hepatic graft-versus-host disease: potential clue for diagnosis and distinguishing acute and chronic form. Transpl Immunol 2010; 23: 77-80.
24. Bouron-Dal Soglio D, Rougemont AL, Herzog D, Soucy G, Alvarez F, Fournet JC,. An immunohistochemical evaluation of C4d deposition in pediatric inflammatory liver diseases. Hum Pathol 2008; 39: 1103-1110. (Pubitemid 351822384)
25. Bu X, Zheng Z, Yu Y, Zeng L, Jiang Y,. Significance of C4d deposition in the diagnosis of rejection after liver transplantation. Transplant Proc 2006; 38: 1418-1421.
26. Seemayer CA, Gaspert A, Nickeleit V, Mihatsch MJ,. C4d staining of renal allograft biopsies: a comparative analysis of different staining techniques. Nephrol Dial Transplant 2007; 22: 568-576. (Pubitemid 46189903)
27. Rensen SS, Slaats Y, Driessen A, Peutz-Kootstra CJ, Nijhuis J, Steffensen R, et al. Activation of the complement system in human nonalcoholic fatty liver disease. Hepatology 2009; 50: 1809-1817.
28. Zwirner J, Felber E, Herzog V, Riethmüller G, Feucht HE,. Classical pathway of complement activation in normal and diseased human glomeruli. Kidney Int 1989; 36: 1069-1077. (Pubitemid 20049214)
29. Loupy A, Hill GS, Suberbielle C, Charron D, Anglicheau D, Zuber J, et al. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant 2011; 11: 56-65.
30. Einecke G, Sis B, Reeve J, Mengel M, Campbell PM, Hidalgo LG, et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-2531.